Navigation Links
Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis

IRVINE, Calif.--(BUSINESS WIRE)--Jul 6, 2007 - Cobalis Corp. (OTCBB:CLSC), a pharmaceutical development company specializing in anti-allergy medications, today reported preliminary top-line results from two Phase III clinical trials for its drug PreHistin(TM) in patients with moderate to moderately severe seasonal allergic rhinitis, commonly known as hay fever. The trials showed very low symptom levels in both placebo and PreHistin-treated patient groups, thereby leaving no room to demonstrate a meaningful drug effect.

In the randomized, six week, placebo-controlled trials involving a total of 1,551 subjects, PreHistin did not achieve statistically significant differences from placebo in the primary measure of efficacy, the reduction in total nasal symptom score (TNSS). However, the TNSS data for placebo-treated patients was far lower than would be expected for the moderate to moderately severe patient population called for in the protocol. Low pollen counts in many of the regions during the time PreHistin was being tested may have resulted in low mean placebo symptom scores for the overall study population.

The trials showed that PreHistin was well tolerated and thus contributed positively to the safety record of PreHistin's active ingredient, cyanocobalamin.

A comparison of pre- and post-treatment blood levels of cobalamin demonstrated for the first time in a large study population that delivery of cyanocobalamin via sublingual lozenges resulted in significant increases in cobalamin blood levels.

Cobalis' Chief Scientific Officer Ernest Armstrong commented: "Showing a meaningful reduction in allergy symptoms when the symptoms never increased throughout the pollen season to the desired moderate to moderately severe level is next to impossible. It's like trying to prove that a pump can pump water out of a swimming pool when there is almost no water in the pool to begin with. Other pharmaceu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cobalis Expects to Report Phase III Top-Line Results in May
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:6/2/2015)... 2, 2015 REPORT HIGHLIGHTS ... $3.7 billion in 2013. This market is expected to increase ... billion in 2019, with compound annual growth rate (CAGR) of ... This report provides: An in-depth analysis of ... market trends, with data from 2013, estimates for 2014, and ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of Jain PharmaBiotech,s new report ... Technologies, Markets and Companies" to their offering. ... nervous system (CNS) is a challenge in the ... directly into the CNS or administered systematically (e.g., ...
(Date:6/2/2015)... 2015 The North American ... concerned market with analysis and forecast of revenue. ... 2014, and is estimated to reach $632.5 million ... 2014 to 2019. Browse through the ... an analysis of industry trends and segments, with ...
Breaking Medicine Technology:Global Markets and Technologies for Medical Lasers 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
(Date:6/2/2015)... Highly qualified dental care specialists inside the leading ... change in the dental tourism industry in Europe. As dentistry ... offers a full range of superior dental services in its ... , Partnered with a top medical tourism agency , ... and has earned a reputation as an influential provider for ...
(Date:6/2/2015)... 02, 2015 The Down Syndrome Association ... from the hit show Glee as the keynote speaker ... in Pleasant Prairie, WI. The event aims to raise ... Racine, Kenosha, and Walworth counties. , ... us for this important event," says Dawn Nuoffer, DSAW ...
(Date:6/2/2015)... Los Angeles (PRWEB) June 02, 2015 ... a letter of intent to partner and expand urgent ... is subject to approval by the University of California ... The planned transaction will allow UCLA Health to purchase ... centers in Beverly Hills, Calabasas, Newbury Park and Northridge ...
(Date:6/2/2015)... The Horizon Blue Cross Blue Shield ... Walking and Wellness Challenge, held this past weekend during ... another $3,000 for the Boys & Girls Club of ... 32,000 steps on her fitbit during her play at ... Club in Galloway Township. , When added to ...
(Date:6/2/2015)... 2015 Bitscape Infotech today announced it ... Worldwide Small and Midsized Cloud Solutions Award. The company ... partners for demonstrating excellence in innovation and implementation of ... comes as no surprise to us as we feel ... at worldwide level by Microsoft. We will continue to ...
Breaking Medicine News(10 mins):Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3
... Expected to Increase Annual Sales by 14.4 Million ... China Kangtai,Cactus Biotech Inc. (the "Company") (OTC Bulletin ... marketer of a,variety of cactus-based consumer products in ... products, Cactus Cattle Feed and Cactus Fish,Feed. It ...
... heart health, at least among men, a new study ... Gramling, M.D., D.Sc., found that men who believed they ... a three times lower incidence of death from heart ... the same conclusion among women. One possible explanation for ...
... how to reduce data security risks within their organization. , ... ... Kroll Fraud Solutions today launched " Handling Sensitive Patient Information ... healthcare professionals. , , ,From custodians and receptionists to nurses and ...
... Business Offers Premier Combat Lifesaver ... ... 14 In the summer of 2005, the,U.S. Army approached ... the requirements for the Combat Lifesaver program, and,at gaining their ...
... Experience 100 Million ... and Depend Upon, SAN FRANCISCO, July 14 BabyCenter, ... the world, announced,today the launch of a new social network. ... other and builds upon the,experience and expert voice parents have ...
... online NHS Health Guide for people,with diabetes has ... Choices, http://www.nhs.uk , The guide, http://www.nhs.uk/Pathways/diabetes/Pages/Landing.aspx, ... through to how to,live and self-manage the condition. ... out more guides from the 60 most common ...
Cached Medicine News:Health News:China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed 2Health News:Positive thinking is prescription for the heart 2Health News:Kroll Fraud Solutions Launches "Handling Sensitive Patient Information in the Healthcare Workplace: An eLearning Course for Safeguarding Patient Data" 2Health News:Creator of Recon Moutaineer's Tactical Combat Casualty Care Bag Praises Combat Lifesavers 2Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 2Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 3Health News:Diabetes Online Health Guide Released on NHS Choices 2
... with the CRW system for simplified functional ... cable drive mechanism to mimic the control ... of fluid leakage. The modular design of ... simplified removal during deep brain stimulator implantation. ...
... The OEV-203 Monitors are designed exclusively for ... use with all Olympus endoscopy systems. When ... equipment, the OEV-203 provides sharp, high-resolution images ... with the view - and details - ...
... lines of resolution with RGB, s-video and composite ... size selection and DC output availability. The on ... set up and operate the medical grade monitor. ... volume and aperture control. It also features a ...
... The Sony LMD-181MD medical grade flat panel is designed ... is perfect for endoscopy, surgery, radiology and ultrasound. It ... used on a overhead surgical arm. It allows for ... board and also has a built in VGA input. ...
Medicine Products: